drugset
drugset / Trial / NCT03140033

Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery

NCT03140033 ↗

Phase 2 Unknown 158 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery : A Randomized Controlled Trial

Timeline

Start
2016-07
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 400 ug Other

Indications

pregnancy disorder